Series A Round

Inductive Bio is a platform that accelerates the discovery of life-changing therapeutics using state-of-the-art AI models and expert-guided generative chemistry. The recent funding will enhance its machine learning capabilities to predict ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of small molecules, thereby transforming small molecule drug discovery. This funding round aims to further develop their proprietary algorithms and expand their team of experts in AI and chemistry. The investment will also support the scaling of their platform to improve the efficiency and accuracy of drug candidate selection. The company is positioned to significantly impact the pharmaceutical industry by streamlining the drug development process and reducing time-to-market for new therapies.